about
A brief review of recent Charcot-Marie-Tooth research and prioritiesIncentives for Starting Small Companies Focused on Rare and Neglected DiseasesCollaboration for rare disease drug discovery researchCollecting rare diseasesThe value of translational biomarkers to phenotypic assays.Challenges and Hurdles to Business as Usual in Drug Development for Treatment of Rare Diseases.Industrializing rare disease therapy discovery and development.
P2860
Q27012700-5203CEF0-D457-4D30-8009-0BDC1DD93149Q27657368-A160A2AC-42BF-45FE-9B1A-4AB3D463F123Q28650560-E59D20BF-6B39-4E3F-8170-C2FB490E174BQ28652456-211595A7-E126-4BD6-8C32-6B5DB99461C1Q42649917-A332654E-EB5E-42B8-8229-2F262946AAD6Q46138897-8FEAE34F-8134-4E7A-BF2F-E753F6F58ABAQ48261810-04D376AB-DFE0-481B-AF77-7E900843344A
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The discovery of medicines for rare diseases
@en
The discovery of medicines for rare diseases.
@nl
type
label
The discovery of medicines for rare diseases
@en
The discovery of medicines for rare diseases.
@nl
prefLabel
The discovery of medicines for rare diseases
@en
The discovery of medicines for rare diseases.
@nl
P2860
P356
P1476
The discovery of medicines for rare diseases
@en
P2093
David C Swinney
Shuangluo Xia
P2860
P304
P356
10.4155/FMC.14.65
P577
2014-06-01T00:00:00Z